课题基金 / 基金详情

Analyses of a Novel Signaling Molecule, Cas

Analyses of a Novel Signaling Molecule, Cas
新型信号分子 Cas 的分析
批准号:
09044271
负责人:
HIRAI Hisamaru
金额:
$5.44万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for international Scientific Research
财政年份:
1997
资助国家:
日本
项目状态:
已结题
起止时间:
1997 至 1998

项目摘要

项目成果

HIRAI Hisamaru的其他基金

相似基金

相关文献

中文摘要
翻译
P13OCas是一种具有SH3结构域和底物结构域中多个SH2结合基序的适配蛋白。它还在C末端附近含有一个酪氨酸残基和一个富含Pro的序列,这两个序列分别是Src激酶SH2和SH3结构域的结合部位。在整合素刺激下,CAS被诱导酪氨酸磷酸化。我们研究了GAS的亚细胞定位,并确定了其定位到焦点粘连所需的区域。在未转化的细胞中,Cas主要定位于细胞质,部分定位于灶性粘连。然而,在527F-c-Src转化的细胞中,Gas主要定位于足体。在表达激酶阴性的527F/295M-c-Src的细胞中,观察到Cas定位于局灶性粘连。在未转化的细胞中,CaS的SH3结构域是其与焦点粘连定位所必需的,而在527F-c-Src-Transfo…中,CaS的SH3结构域和C末端的Src结合域都是必需的更多的rmed细胞和纤维连接蛋白刺激的细胞。此外,在Src阴性细胞中,Gas对局灶性粘连的定位被取消。这些结果表明,CaS的SH3结构域和CaS与Src激酶的结合在GAS对局灶性粘连的定位中起着关键作用。为了确定它在体内的作用,我们培育了缺乏气体的小鼠。缺气胚胎在宫内死亡,表现出明显的全身充血和生长迟缓。组织学上,心脏发育不良,血管明显扩张。心脏的电子显微镜分析显示肌原纤维的解体和Z盘的破坏。此外,在CaS缺乏的原代成纤维细胞中,肌动蛋白应激纤维的形成严重受损。此外,在CaS缺乏的原代成纤维细胞中表达激活的Src并没有诱导完全转化的表型,这可能是由于足体中肌动蛋白细胞骨架的积累不足所致。这些发现明确了Gas在心血管发育、肌动蛋白细丝组装和Src诱导的转化中的作用。较少
英文摘要
p13OCas is an adapter protein that has an SH3 domain followed by multiple SH2 binding motifs in the substrate domain. It also contains a tyrosine residue and a proline-rich sequence near the C terminus, which are the binding sites for the SH2 and SH3 domains of Src kinase, respectively. Cas was shown to be inducibly tyrosine phosphorylated upon integrin stimulation. We examined the subcellular localization of Gas and determined the regions required for its localization to focal adhesions. In nontransformed cells, Cas was localized predominantly to the cytoplasm and partially to focal adhesions. However, in 527F-c-Src-transformed cells, Gas was localized mainly to podosomes. The localization of Cas to focal adhesions was observed in cells expressing the kinase-negative 527F/295M-c-Src. The SH3 domain of Cas is necessary for its localization to focal adhesions in nontransformed cells while both the SH3 domain and the C-terminal Src binding domain of Cas are required in 527F-c-Src-transfo … More rmed cells and fibronectin-stimulated cells. In addition, the localization of Gas to focal adhesions was abolished in Src-negative cells. These results demonstrate that the SH3 domain of Cas and the association of Cas with Src kinase play a pivotal role in the localization of Gas to focal adhesions. To determine its role in vivo, we generated mice lacking Gas. Gas-deficient embryos died in utero showing marked systemic congestion and growth retardation. Histologically, the heart was poorly developed and blood vessels were prominently dilated. Electron microscopic analysis of the heart revealed disorganization of myofibrils and disruption of Z-disks. In addition, actin stress fiber formation was severely impaired in Cas-deficient primary fibroblasts. Moreover, expression of activated Src in Cas-deficient primary fibroblasts did not induce a fully transformed phenotype, possibly owing to insufficient accumulation of actin cytoskeleton in podosomes. These findings have defined Gas function in cardiovascular development, actin filament assembly and Src-induced transformation. Less
期刊论文(24)
专著(0)
科研奖励(0)
会议论文
Sakai R: "Characterization of the kinase activity essential for tyrosine phosphorylation of p130Cas in mouse fibroblasts." Oncogene. 14. 1419-1426 (1997)
Sakai R:“小鼠成纤维细胞中 p130Cas 酪氨酸磷酸化所必需的激酶活性的表征。”
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Astier A: "The related adhesion focal tyrosine kinase differentially phosphorylates p130Cas and the Cas-like protein, p105HEF1." J.Biol.Chem.272. 4230-4236 (1997)
Astier A:“相关的粘附局灶酪氨酸激酶对 p130Cas 和 Cas 样蛋白 p105HEF1 进行差异磷酸化。”
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Kanda H: "Ligation of the T cell antigen receptor induces tyrosine phosphorylation of p105CasL, a member of the p130Cas-related docking protein family, and its subsequent binding to the Src homology 2 domain of c-Crk." Eur.J.Immunol.27. 2113-2117 (1997)
Kanda H:“T 细胞抗原受体的连接诱导 p105CasL(p130Cas 相关对接蛋白家族的成员)的酪氨酸磷酸化,以及随后与 c-Crk 的 Src 同源 2 结构域的结合。”
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Honda H,Oda H,Nakamoto T,Honda Z,Sakai R,Suzuki T,Saito T,Nakamura K,Nakao K,Ishikawa T,Katsuki M,Yazaki Y,Hirai H.: "Cardiovascular anomaly, impaired actin bundling and resistance to Src-induced transformation in mice lacking p130Cas." Nature Genet. 19.
Honda H、Oda H、Nakamoto T、Honda Z、Sakai R、Suzuki T、Saito T、Nakamura K、Nakao K、Ishikawa T、Katsuki M、Yazaki Y、Hirai H.:“心血管异常、肌动蛋白成束受损和抵抗力
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
共 17 条
    Analyses of Maltipotential Functions of a Novel Signaling Molecule, Cas
    • 批准号:
      11694250
    • 项目类别:
      Grant-in-Aid for Scientific Research (A).
    • 资助金额:
      $5.57万
    • 财政年份:
      1999
    • 负责人:
      HIRAI Hisamaru
    • 依托单位:
    Practical development of a novel method for hematopoietic stem cell expansion
    • 批准号:
      09357010
    • 项目类别:
      Grant-in-Aid for Scientific Research (A)
    • 资助金额:
      $18.24万
    • 财政年份:
      1997
    • 负责人:
      HIRAI Hisamaru
    • 依托单位:
    Analysis of molecular mechanisms of leukemia development
    • 批准号:
      09307021
    • 项目类别:
      Grant-in-Aid for Scientific Research (A)
    • 资助金额:
      $24.58万
    • 财政年份:
      1997
    • 负责人:
      HIRAI Hisamaru
    • 依托单位:
    Analysis of Molecular Mechanism of Blastic Crisis in Chronic Myelocytic Leukemia
    • 批准号:
      07042002
    • 项目类别:
      Grant-in-Aid for international Scientific Research
    • 资助金额:
      $3.65万
    • 财政年份:
      1995
    • 负责人:
      HIRAI Hisamaru
    • 依托单位:
    国内基金
    海外基金
    桑黄新菌株 SH3 抗肝癌活性代谢产物的鉴定及功能分析
    • 批准号:
      2022JJ40233
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2022
    • 负责人:
      唐少军
    • 依托单位:
    LIM和SH3蛋白1通过介导糖代谢重组诱导胃癌曲妥珠单抗耐药的机制研究
    • 批准号:
    • 项目类别:
      省市级项目
    • 资助金额:
      10.0万元
    • 批准年份:
      2019
    • 负责人:
      史蛟龙
    • 依托单位:
    SH3结构域蛋白Dlish调控果蝇Hippo信号通路的分子机制研究
    • 批准号:
      31801190
    • 项目类别:
      青年科学基金项目
    • 资助金额:
      23.0万元
    • 批准年份:
      2018
    • 负责人:
      王兴
    • 依托单位:
    c-Src的SH3结构域作为低出血风险的抗血栓新靶点的研究
    • 批准号:
      81670127
    • 项目类别:
      面上项目
    • 资助金额:
      60.0万元
    • 批准年份:
      2016
    • 负责人:
      奚晓东
    • 依托单位: